Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03036735Not ApplicableTerminated

Rates of Middle Meatus Synechiae Formation Post ESS

Role: collaborator

NCT02463279Not ApplicableCompleted

SinuSys Patency of Frontal Recess and Sphenoid Sinus Ostia Study

Role: lead

NCT01623050Phase 1Completed

Safety and Performance of the SinuSys Dilation System for Dilation of the Maxillary Sinus Ostium

Role: lead

All 3 trials loaded